AISHA LOUISE SALDANHA's Insider Trades & SAST Disclosures
AISHA LOUISE SALDANHA's most recent trade in Glenmark Pharmaceuticals Ltd. was a Disposal of 10,000 Equity Shares done . Disclosure was reported to the exchange on Sept. 29, 2021 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
No reported SAST transactions available for AISHA LOUISE SALDANHA in the Trendlyne database.
| Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Glenmark Pharma | AISHA LOUISE SALDANHA | Promoters Immediate Relative | Disposal | 29 Sep 2021 | 10,000 | 0 (0%) | 0.00% | 0 | 0 | 27 Sep 2021 27 Sep 2021 |
Insider Trading | Equity Shares | Gift |
| Glenmark Pharma | AISHA LOUISE SALDANHA | Promoters Immediate Relative | Acquisition | 16 Nov 2020 | 10,000 | 10,000 (0%) | 0.00% | 487.7 | 4,877,192 | 13 Nov 2020 13 Nov 2020 |
Insider Trading | Equity Shares | Market Purchase |
Acquisition (Buy): Purchase of shares
Disposal (Sell): Sale of shares
Pledge: Shares being used by promoters as collateral for loans. Usually a negative signal.
Revoke: When shares are released from a pledge. Usually a positive signal.
Invoke: When pledged shares are invoked by companies/banks who have provided the collateral, which may result in acquisition of stake in the company. Usually a negative signal.
Security Type: Share/ Warrants / Convertible Debentures
Kind of transaction Mode: Public rights/ preferential offer / off market / inter-se transfer/ Market Sale
Data as reported to BSE and NSE
Insider trading data is from Disclosure under SEBI (Prohibition of Insider Trading) Regulations, 2015.